Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.180
+0.030 (0.95%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$298,741
Profits / Employee
-$41,704
Market Cap
304.17M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,700 | 0 | - |
| Dec 31, 2024 | 2,700 | 0 | - |
| Dec 31, 2023 | 2,700 | 100 | 3.85% |
| Dec 31, 2022 | 2,600 | 200 | 8.33% |
| Dec 31, 2021 | 2,400 | -300 | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 1,002 |
| Burning Rock Biotech | 667 |
| Freenome | 363 |
| Biodesix | 334 |
MYGN News
- 2 days ago - Myriad Genetics, Inc. (MYGN) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel - GlobeNewsWire
- 3 days ago - Myriad Genetics price target lowered to $3 from $5.50 at Wells Fargo - TheFly
- 3 days ago - Myriad Genetics price target lowered to $3.20 from $4 at BofA - TheFly
- 6 days ago - Myriad Genetics price target lowered to $4 from $6 at TD Cowen - TheFly
- 7 days ago - Myriad Genetics cuts FY26 revenue view to $770M-$790M from $860M-$880M - TheFly
- 7 days ago - Myriad Genetics reports Q2 EPS (25c), consensus (6c) - TheFly
- 7 days ago - Myriad Genetics Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Myriad Genetics Earnings release: Q2 2026 - Filings